PharmaShots

JANUARY 27, 2023

Magenta Therapeutics Pauses the P-I/II Study in AML Patients Date: Jan 27, 2023 | Tags: Magenta Therapeutics, MGTA-117, AML, Clinical Trial, P-I/II Ipsen Receives CHMP Negative Opinion for Palovarotene to Treat Fibrodysplasia Ossificans Progressiva Date: Jan 27, 2023 | Tags: Ipsen, Palovarotene, Fibrodysplasia Ossificans Progressiva, Regulatory, CHMP, (..)

FDA 40

FDA Immunization 40

Viseven

FEBRUARY 6, 2023

Any healthcare organization should not underestimate the importance of mobile devices for its target clients. In addition, AI-driven software attracts pharma companies that study its potential in new drug discovery, patient diagnostics automation, and clinical trials which is great for recruitment campaigns.

Communication 75

Communication 75

pharmaphorum

FEBRUARY 26, 2021

One of J&J’s subsidiaries is Ethicon, which is a manufacturer of surgical sutures and wound closure devices. United under the common name of J&J, Janssen is now split into three different businesses – Janssen Research & Development, Janssen Healthcare Innovation and Janssen Diagnostics.

Vaccines 124

Vaccines Labelling Communication 124